Company / FCF Margin
Aquestive Therapeutics, Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-119.0%
FY2025
5-year range
-119.0% / -14.6%
FY2021-FY2025
Trend
-90.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -14.6% to -119.0% over the past 2 years.
Based on SEC 10-K filings.
-119.0% in FY2025 with a 5-year CAGR of -3.3%.
Declined from -14.6% to -119.0% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -96.2pp
- 5-Year Change
- -3.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 90.7% year-over-year.
- Peak fcf margin was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -119.0% | -90.7% |
| FY2024 | -62.4% | -328.0% |
| FY2023 | -14.6% | +35.9% |
| FY2022 | -22.7% | +77.3% |
| FY2021 | -100.3% | +13.3% |
| FY2020 | -115.7% | -426.7% |
| FY2019 | -22.0% | -491.6% |
| FY2018 | 5.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026